Incidence and predictors of antiretroviral resistance in perinatally HIV-1 infected children and adolescents
Objectives Individuals with perinatally acquired HIV infection have benefited from antiretroviral therapy. However, they often have complex patterns of major resistance mutations that limit the effectiveness of available antiretroviral medications. Knowledge of incidence rates of major antiretrovira...
- Autores:
-
Contreras, German A.
Bell, Cynthia S.
Del Bianco, Gabriela
Pérez, Norma
Benjamins, Laura
Kleinosky, Matthew T.
Rodriguez, Gilhen
Murphy, James R.
Heresi, Gloria P.
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2016
- Institución:
- Universidad El Bosque
- Repositorio:
- Repositorio U. El Bosque
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.unbosque.edu.co:20.500.12495/3635
- Acceso en línea:
- http://hdl.handle.net/20.500.12495/3635
https://doi.org/10.1016/j.jinf.2015.12.005
https://repositorio.unbosque.edu.co
- Palabra clave:
- Incidence rate
Adolescents
HIV
Antiretroviral resistance
Cumulative viral load
- Rights
- openAccess
- License
- Acceso abierto
id |
UNBOSQUE2_b364e8faaf6696e20435a14931b0434c |
---|---|
oai_identifier_str |
oai:repositorio.unbosque.edu.co:20.500.12495/3635 |
network_acronym_str |
UNBOSQUE2 |
network_name_str |
Repositorio U. El Bosque |
repository_id_str |
|
dc.title.spa.fl_str_mv |
Incidence and predictors of antiretroviral resistance in perinatally HIV-1 infected children and adolescents |
dc.title.translated.spa.fl_str_mv |
Incidence and predictors of antiretroviral resistance in perinatally HIV-1 infected children and adolescents |
title |
Incidence and predictors of antiretroviral resistance in perinatally HIV-1 infected children and adolescents |
spellingShingle |
Incidence and predictors of antiretroviral resistance in perinatally HIV-1 infected children and adolescents Incidence rate Adolescents HIV Antiretroviral resistance Cumulative viral load |
title_short |
Incidence and predictors of antiretroviral resistance in perinatally HIV-1 infected children and adolescents |
title_full |
Incidence and predictors of antiretroviral resistance in perinatally HIV-1 infected children and adolescents |
title_fullStr |
Incidence and predictors of antiretroviral resistance in perinatally HIV-1 infected children and adolescents |
title_full_unstemmed |
Incidence and predictors of antiretroviral resistance in perinatally HIV-1 infected children and adolescents |
title_sort |
Incidence and predictors of antiretroviral resistance in perinatally HIV-1 infected children and adolescents |
dc.creator.fl_str_mv |
Contreras, German A. Bell, Cynthia S. Del Bianco, Gabriela Pérez, Norma Benjamins, Laura Kleinosky, Matthew T. Rodriguez, Gilhen Murphy, James R. Heresi, Gloria P. |
dc.contributor.author.none.fl_str_mv |
Contreras, German A. Bell, Cynthia S. Del Bianco, Gabriela Pérez, Norma Benjamins, Laura Kleinosky, Matthew T. Rodriguez, Gilhen Murphy, James R. Heresi, Gloria P. |
dc.subject.keywords.spa.fl_str_mv |
Incidence rate Adolescents HIV Antiretroviral resistance Cumulative viral load |
topic |
Incidence rate Adolescents HIV Antiretroviral resistance Cumulative viral load |
description |
Objectives Individuals with perinatally acquired HIV infection have benefited from antiretroviral therapy. However, they often have complex patterns of major resistance mutations that limit the effectiveness of available antiretroviral medications. Knowledge of incidence rates of major antiretroviral resistance mutations should provide a benchmark enabling comparisons of different HIV care delivery modalities. Methods We test the hypothesis that incidence rate of major antiretroviral resistance mutations will decline with improvement in HIV care between 1998 and 2009 to NRTI, NNRTI, PI and triple class resistance in perinatally HIV infected individuals. Logistic regression is used to evaluate predictors of single and triple class resistance. Results Sixty-six individuals are included from a total population of 97 perinatally HIV infected individuals. The incidence rate of NRTI, NNRTI, PI and triple class resistance decreases with decreasing age in parallel with the introduction of new HIV treatment regimens. The youngest children (born 2000–2007) are free of triple class resistance. Mono-therapy associates with major resistance mutations to NRTI (OR 8.7, CI 1.5–50.9, P 0.02); NNRTI exposure associates with major resistance mutations to NNRTI (OR 24.4, CI 5.7–104.5, P 0.01) and triple class resistance (OR 10.7, CI 1.8–67.1, P 0.01). Cumulative viral load is an important predictor of PI resistance (OR 4.0, CI 1.3–12.3, P 0.02). Conclusions There is a progressive decrease in the incidence rate of major resistance mutations to antiretroviral drugs and triple class resistance from the oldest to the youngest birth cohort; where adolescents have the highest risk of harboring resistant viruses. The incidence rate of major antiretroviral resistance mutations provides a benchmark for the comparative measurement of effectiveness of different HIV care delivery modalities. |
publishDate |
2016 |
dc.date.issued.none.fl_str_mv |
2016 |
dc.date.accessioned.none.fl_str_mv |
2020-07-31T15:31:07Z |
dc.date.available.none.fl_str_mv |
2020-07-31T15:31:07Z |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.local.none.fl_str_mv |
Artículo de revista |
dc.type.coar.none.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.driver.none.fl_str_mv |
info:eu-repo/semantics/article |
format |
http://purl.org/coar/resource_type/c_6501 |
dc.identifier.issn.none.fl_str_mv |
0163-4453 |
dc.identifier.uri.none.fl_str_mv |
http://hdl.handle.net/20.500.12495/3635 |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.1016/j.jinf.2015.12.005 |
dc.identifier.instname.spa.fl_str_mv |
instname:Universidad El Bosque |
dc.identifier.reponame.spa.fl_str_mv |
reponame:Repositorio Institucional Universidad El Bosque |
dc.identifier.repourl.none.fl_str_mv |
https://repositorio.unbosque.edu.co |
identifier_str_mv |
0163-4453 instname:Universidad El Bosque reponame:Repositorio Institucional Universidad El Bosque |
url |
http://hdl.handle.net/20.500.12495/3635 https://doi.org/10.1016/j.jinf.2015.12.005 https://repositorio.unbosque.edu.co |
dc.language.iso.none.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartofseries.spa.fl_str_mv |
Journal of Infection, 0163-4453, Vol. 72, Nro. 3, 2016, p.353-361 |
dc.relation.uri.none.fl_str_mv |
https://www.sciencedirect.com/science/article/abs/pii/S016344531500393X |
dc.rights.local.spa.fl_str_mv |
Acceso abierto |
dc.rights.accessrights.none.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 info:eu-repo/semantics/openAccess Acceso abierto |
dc.rights.creativecommons.none.fl_str_mv |
2016-03 |
rights_invalid_str_mv |
Acceso abierto http://purl.org/coar/access_right/c_abf2 2016-03 |
eu_rights_str_mv |
openAccess |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Elsevier |
dc.publisher.journal.spa.fl_str_mv |
Journal of Infection |
institution |
Universidad El Bosque |
bitstream.url.fl_str_mv |
https://repositorio.unbosque.edu.co/bitstreams/347e33b1-df4f-4041-be5a-f20f7712649d/download https://repositorio.unbosque.edu.co/bitstreams/e6728683-ab60-4153-8851-f9629d85e5b2/download https://repositorio.unbosque.edu.co/bitstreams/2d278e26-78e8-4fb5-9033-30f817ee5daa/download https://repositorio.unbosque.edu.co/bitstreams/f72c77d5-f504-4707-b807-2b12a930f9d2/download |
bitstream.checksum.fl_str_mv |
8a4605be74aa9ea9d79846c1fba20a33 cb1da97507c6949cf934360f995e0ba5 7210a811635d1799e7c05fee5d259be7 654216fd5b500f010503fd36821b133d |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio Institucional Universidad El Bosque |
repository.mail.fl_str_mv |
bibliotecas@biteca.com |
_version_ |
1814100703740690432 |
spelling |
Contreras, German A.Bell, Cynthia S.Del Bianco, GabrielaPérez, NormaBenjamins, LauraKleinosky, Matthew T.Rodriguez, GilhenMurphy, James R.Heresi, Gloria P.2020-07-31T15:31:07Z2020-07-31T15:31:07Z20160163-4453http://hdl.handle.net/20.500.12495/3635https://doi.org/10.1016/j.jinf.2015.12.005instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquehttps://repositorio.unbosque.edu.coapplication/pdfengElsevierJournal of InfectionJournal of Infection, 0163-4453, Vol. 72, Nro. 3, 2016, p.353-361https://www.sciencedirect.com/science/article/abs/pii/S016344531500393XIncidence and predictors of antiretroviral resistance in perinatally HIV-1 infected children and adolescentsIncidence and predictors of antiretroviral resistance in perinatally HIV-1 infected children and adolescentsArtículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articlehttp://purl.org/coar/version/c_970fb48d4fbd8a85Incidence rateAdolescentsHIVAntiretroviral resistanceCumulative viral loadObjectives Individuals with perinatally acquired HIV infection have benefited from antiretroviral therapy. However, they often have complex patterns of major resistance mutations that limit the effectiveness of available antiretroviral medications. Knowledge of incidence rates of major antiretroviral resistance mutations should provide a benchmark enabling comparisons of different HIV care delivery modalities. Methods We test the hypothesis that incidence rate of major antiretroviral resistance mutations will decline with improvement in HIV care between 1998 and 2009 to NRTI, NNRTI, PI and triple class resistance in perinatally HIV infected individuals. Logistic regression is used to evaluate predictors of single and triple class resistance. Results Sixty-six individuals are included from a total population of 97 perinatally HIV infected individuals. The incidence rate of NRTI, NNRTI, PI and triple class resistance decreases with decreasing age in parallel with the introduction of new HIV treatment regimens. The youngest children (born 2000–2007) are free of triple class resistance. Mono-therapy associates with major resistance mutations to NRTI (OR 8.7, CI 1.5–50.9, P 0.02); NNRTI exposure associates with major resistance mutations to NNRTI (OR 24.4, CI 5.7–104.5, P 0.01) and triple class resistance (OR 10.7, CI 1.8–67.1, P 0.01). Cumulative viral load is an important predictor of PI resistance (OR 4.0, CI 1.3–12.3, P 0.02). Conclusions There is a progressive decrease in the incidence rate of major resistance mutations to antiretroviral drugs and triple class resistance from the oldest to the youngest birth cohort; where adolescents have the highest risk of harboring resistant viruses. The incidence rate of major antiretroviral resistance mutations provides a benchmark for the comparative measurement of effectiveness of different HIV care delivery modalities.Acceso abiertohttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessAcceso abierto2016-03LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://repositorio.unbosque.edu.co/bitstreams/347e33b1-df4f-4041-be5a-f20f7712649d/download8a4605be74aa9ea9d79846c1fba20a33MD52ORIGINALContreras, German A. I.pdfContreras, German A. I.pdfapplication/pdf633716https://repositorio.unbosque.edu.co/bitstreams/e6728683-ab60-4153-8851-f9629d85e5b2/downloadcb1da97507c6949cf934360f995e0ba5MD51THUMBNAILContreras, German A. I.pdf.jpgContreras, German A. I.pdf.jpgimage/jpeg5775https://repositorio.unbosque.edu.co/bitstreams/2d278e26-78e8-4fb5-9033-30f817ee5daa/download7210a811635d1799e7c05fee5d259be7MD53TEXTContreras, German A. I.pdf.txtContreras, German A. I.pdf.txtExtracted texttext/plain36427https://repositorio.unbosque.edu.co/bitstreams/f72c77d5-f504-4707-b807-2b12a930f9d2/download654216fd5b500f010503fd36821b133dMD5420.500.12495/3635oai:repositorio.unbosque.edu.co:20.500.12495/36352024-02-06 22:56:42.634restrictedhttps://repositorio.unbosque.edu.coRepositorio Institucional Universidad El Bosquebibliotecas@biteca.comTk9URTogUExBQ0UgWU9VUiBPV04gTElDRU5TRSBIRVJFClRoaXMgc2FtcGxlIGxpY2Vuc2UgaXMgcHJvdmlkZWQgZm9yIGluZm9ybWF0aW9uYWwgcHVycG9zZXMgb25seS4KCk5PTi1FWENMVVNJVkUgRElTVFJJQlVUSU9OIExJQ0VOU0UKCkJ5IHNpZ25pbmcgYW5kIHN1Ym1pdHRpbmcgdGhpcyBsaWNlbnNlLCB5b3UgKHRoZSBhdXRob3Iocykgb3IgY29weXJpZ2h0Cm93bmVyKSBncmFudHMgdG8gRFNwYWNlIFVuaXZlcnNpdHkgKERTVSkgdGhlIG5vbi1leGNsdXNpdmUgcmlnaHQgdG8gcmVwcm9kdWNlLAp0cmFuc2xhdGUgKGFzIGRlZmluZWQgYmVsb3cpLCBhbmQvb3IgZGlzdHJpYnV0ZSB5b3VyIHN1Ym1pc3Npb24gKGluY2x1ZGluZwp0aGUgYWJzdHJhY3QpIHdvcmxkd2lkZSBpbiBwcmludCBhbmQgZWxlY3Ryb25pYyBmb3JtYXQgYW5kIGluIGFueSBtZWRpdW0sCmluY2x1ZGluZyBidXQgbm90IGxpbWl0ZWQgdG8gYXVkaW8gb3IgdmlkZW8uCgpZb3UgYWdyZWUgdGhhdCBEU1UgbWF5LCB3aXRob3V0IGNoYW5naW5nIHRoZSBjb250ZW50LCB0cmFuc2xhdGUgdGhlCnN1Ym1pc3Npb24gdG8gYW55IG1lZGl1bSBvciBmb3JtYXQgZm9yIHRoZSBwdXJwb3NlIG9mIHByZXNlcnZhdGlvbi4KCllvdSBhbHNvIGFncmVlIHRoYXQgRFNVIG1heSBrZWVwIG1vcmUgdGhhbiBvbmUgY29weSBvZiB0aGlzIHN1Ym1pc3Npb24gZm9yCnB1cnBvc2VzIG9mIHNlY3VyaXR5LCBiYWNrLXVwIGFuZCBwcmVzZXJ2YXRpb24uCgpZb3UgcmVwcmVzZW50IHRoYXQgdGhlIHN1Ym1pc3Npb24gaXMgeW91ciBvcmlnaW5hbCB3b3JrLCBhbmQgdGhhdCB5b3UgaGF2ZQp0aGUgcmlnaHQgdG8gZ3JhbnQgdGhlIHJpZ2h0cyBjb250YWluZWQgaW4gdGhpcyBsaWNlbnNlLiBZb3UgYWxzbyByZXByZXNlbnQKdGhhdCB5b3VyIHN1Ym1pc3Npb24gZG9lcyBub3QsIHRvIHRoZSBiZXN0IG9mIHlvdXIga25vd2xlZGdlLCBpbmZyaW5nZSB1cG9uCmFueW9uZSdzIGNvcHlyaWdodC4KCklmIHRoZSBzdWJtaXNzaW9uIGNvbnRhaW5zIG1hdGVyaWFsIGZvciB3aGljaCB5b3UgZG8gbm90IGhvbGQgY29weXJpZ2h0LAp5b3UgcmVwcmVzZW50IHRoYXQgeW91IGhhdmUgb2J0YWluZWQgdGhlIHVucmVzdHJpY3RlZCBwZXJtaXNzaW9uIG9mIHRoZQpjb3B5cmlnaHQgb3duZXIgdG8gZ3JhbnQgRFNVIHRoZSByaWdodHMgcmVxdWlyZWQgYnkgdGhpcyBsaWNlbnNlLCBhbmQgdGhhdApzdWNoIHRoaXJkLXBhcnR5IG93bmVkIG1hdGVyaWFsIGlzIGNsZWFybHkgaWRlbnRpZmllZCBhbmQgYWNrbm93bGVkZ2VkCndpdGhpbiB0aGUgdGV4dCBvciBjb250ZW50IG9mIHRoZSBzdWJtaXNzaW9uLgoKSUYgVEhFIFNVQk1JU1NJT04gSVMgQkFTRUQgVVBPTiBXT1JLIFRIQVQgSEFTIEJFRU4gU1BPTlNPUkVEIE9SIFNVUFBPUlRFRApCWSBBTiBBR0VOQ1kgT1IgT1JHQU5JWkFUSU9OIE9USEVSIFRIQU4gRFNVLCBZT1UgUkVQUkVTRU5UIFRIQVQgWU9VIEhBVkUKRlVMRklMTEVEIEFOWSBSSUdIVCBPRiBSRVZJRVcgT1IgT1RIRVIgT0JMSUdBVElPTlMgUkVRVUlSRUQgQlkgU1VDSApDT05UUkFDVCBPUiBBR1JFRU1FTlQuCgpEU1Ugd2lsbCBjbGVhcmx5IGlkZW50aWZ5IHlvdXIgbmFtZShzKSBhcyB0aGUgYXV0aG9yKHMpIG9yIG93bmVyKHMpIG9mIHRoZQpzdWJtaXNzaW9uLCBhbmQgd2lsbCBub3QgbWFrZSBhbnkgYWx0ZXJhdGlvbiwgb3RoZXIgdGhhbiBhcyBhbGxvd2VkIGJ5IHRoaXMKbGljZW5zZSwgdG8geW91ciBzdWJtaXNzaW9uLgo= |